Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation

被引:452
作者
Wabitsch, M
Brenner, RE
Melzner, I
Braun, M
Möller, P
Heinze, E
Debatin, KM
Hauner, H
机构
[1] Univ Ulm, Dept Pediat, D-89075 Ulm, Germany
[2] Univ Ulm, Dept Orthopaed, D-89075 Ulm, Germany
[3] Univ Ulm, Dept Pathol, D-89075 Ulm, Germany
[4] Univ Dusseldorf, Diabet Res Inst, D-4000 Dusseldorf, Germany
关键词
human adipocyte; human preadipocyte; differentiation; peroxisome proliferator activated receptor gamma;
D O I
10.1038/sj.ijo.0801520
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To develop and to characterize a human preadipocyte cell strain with high capacity for adipose differentiation serving as a model for studying human adipocyte development and metabolism in vitro. METHODS: Cells were derived from the stromal cells fraction of subcutaneous adipose tissue of an infant with Simpson-Golabi-Behmel syndrome (SGBS). Adipose differentiation was induced under serum-free culture conditions by exposure to 10 nM insulin, 200 pM triiodothyronine, 1 muM cortisol and 2 muM BRL 49653, a PPAR; agonist. RESULTS: During the differentiation process SGBS cells developed a gene expression pattern similar to that found in differentiating human preadipocytes with a characteristic increase in fat cell-specific mRNAs encoding lipoprotein lipase (LPL), glycero-3-phosphate dehydrogenase (GPDH), GLUT4, leptin and others. Differentiated SGBS cells exhibited an increase in glucose uptake upon insulin stimulation and in glycerol release upon catecholamine exposure. SGBS adipocytes were morphologically, biochemically and functionally identical to in vitro differentiated adipocytes from healthy subjects. However, while preadipocytes from healthy control infants rapidly lost their capacity to differentiate after a few cell divisions in culture, SGBS cells maintained their differentiation capacity over many generations: upon appropriate stimulation 95% of SGBS cells of generation 30 developed into adipocytes. A mutation in the glypican 3 gene was not detected in the patient. Thus, it remains unclear whether the molecular alteration in SGBS cells is also responsible for the high differentiation capacity and further investigations are required. CONCLUSION: The human cell strain described here provides an almost unlimited source of human preadipocytes with high capacity for adipose differentiation and may, therefore, represent a unique tool for studying human fat cell development and metabolism.
引用
收藏
页码:8 / 15
页数:8
相关论文
共 28 条
[1]  
AILHAUD G, 1997, HDB OBESITY, P359
[2]   A NEW X-LINKED DYSPLASIA GIGANTISM SYNDROME - IDENTICAL WITH THE SIMPSON DYSPLASIA SYNDROME [J].
BEHMEL, A ;
PLOCHL, E ;
ROSENKRANZ, W .
HUMAN GENETICS, 1984, 67 (04) :409-413
[3]  
Blum WF, 1997, J CLIN ENDOCR METAB, V82, P2904, DOI 10.1210/jc.82.9.2904
[4]  
BUNGE S, METHODS MOL GENETICS, P26
[5]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[6]   OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth Syndrome, induces apoptosis in a cell line-specific manner [J].
Duenas-Gonzalez, A ;
Kaya, M ;
Shi, W ;
Song, H ;
Testa, JR ;
Penn, LZ ;
Filmus, J .
JOURNAL OF CELL BIOLOGY, 1998, 141 (06) :1407-1414
[7]   QUANTITATIVE-ANALYSIS OF COMPARATIVE GENOMIC HYBRIDIZATION [J].
DUMANOIR, S ;
SCHROCK, E ;
BENTZ, M ;
SPEICHER, MR ;
JOOS, S ;
RIED, T ;
LICHTER, P ;
CREMER, T .
CYTOMETRY, 1995, 19 (01) :27-41
[8]   ESTABLISHMENT OF A HUMAN CELL-LINE AFTER TRANSFORMATION BY A PLASMID CONTAINING THE EARLY REGION OF THE SV40 GENOME [J].
FOREST, C ;
CZERUCKA, D ;
NEGREL, R ;
AILHAUD, G .
CELL BIOLOGY INTERNATIONAL REPORTS, 1983, 7 (01) :73-81
[9]   A NEW X-LINKED MENTAL-RETARDATION OVERGROWTH SYNDROME [J].
GOLABI, M ;
ROSEN, L .
AMERICAN JOURNAL OF MEDICAL GENETICS, 1984, 17 (01) :345-358
[10]   PROMOTING EFFECT OF GLUCOCORTICOIDS ON THE DIFFERENTIATION OF HUMAN ADIPOCYTE PRECURSOR CELLS CULTURED IN A CHEMICALLY DEFINED MEDIUM [J].
HAUNER, H ;
ENTENMANN, G ;
WABITSCH, M ;
GAILLARD, D ;
AILHAUD, G ;
NEGREL, R ;
PFEIFFER, EF .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (05) :1663-1670